PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+16.95%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.93B
AUM Growth
+$1.93B
(+10%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
6.26%
Top 10 Holdings %
Top 10 Hldgs %
49.18%
Holding
191
New
20
Increased
30
Reduced
38
Closed
68
Top Buys
| 1 |
Puma Biotechnology
PBYI
|
$64.1M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$58.2M |
| 3 |
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
|
$38M |
| 4 |
CORI
Corium International, Inc.
CORI
|
$23.8M |
| 5 |
Intuitive Surgical
ISRG
|
$19.4M |
Top Sells
| 1 |
Aclaris Therapeutics
ACRS
|
$37.6M |
| 2 |
Sarepta Therapeutics
SRPT
|
$23M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$20.4M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$14.6M |
| 5 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$12.6M |
Sector Composition
| 1 | Healthcare | 96.53% |
| 2 | Consumer Discretionary | 0.06% |
| 3 | Energy | 0.04% |
| 4 | Industrials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
176
DELISTED
Array Biopharma Inc
ARRY
| – | – |
-25,510
| Closed | -$228K |
|
|
SGYP
177
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| – | – |
-978,100
| Closed | -$4.56M |
|
|
CASC
178
DELISTED
Cascadian Therapeutics, Inc.
CASC
| – | – |
-1,966
| Closed | -$8K |
|
|
RXDX
179
DELISTED
Ignyta, Inc.
RXDX
| – | – |
-6,584
| Closed | -$57K |
|
|
PPHMP
180
DELISTED
Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible
PPHMP
| – | – |
-200,000
| Closed | -$4.34M |
|
|
CBPO
181
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| – | – |
-236
| Closed | -$24K |
|
|
TNGN
182
DELISTED
TENGION INC COM NEW STK (DE)
TNGN
| – | – |
-1,826,399
| Closed | -$3K |
|
|
XIV
183
DELISTED
VelocityShares Daily Inverse VIX Short Term ETN
XIV
| – | – |
-16
| Closed | -$1K |
|
184
Ultragenyx Pharmaceutical
RARE
$3.04B
| – | – |
0
| – | – |
|